Clinical trials: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

• Active, not recruiting
• Age: 18 years and older
• Phase 2
• Surgery or procedure

This pilot phase I/II trial studies the side effects and how well nivolumab and ipilimumab in combination with chemotherapy and radiation therapy work in treating patients with gastric cancer that can be removed by surgery.

Conditions

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8

Trial name

NCT03776487

Testing

Fluorouracil, Intensity-Modulated Radiation Therapy, Ipilimumab

Where

United States

Volunteers

32 people

Sponsor

M.D. Anderson Cancer Center